Basel Medical Group Ltd
BMGL
$0.77
-$0.09-10.37%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 31.90% | 25.93% | 0.14% | 1.25% | 5.29% |
| Total Other Revenue | 111.94% | 102.31% | 212.50% | 212.50% | 785.00% |
| Total Revenue | 37.63% | 31.40% | 0.23% | 1.33% | 12.40% |
| Cost of Revenue | 58.94% | 51.74% | 52.10% | 53.77% | 54.34% |
| Gross Profit | 3.44% | -1.24% | -53.64% | -53.13% | -21.75% |
| SG&A Expenses | -5.66% | -9.90% | 3,650.00% | 3,691.67% | -33.28% |
| Depreciation & Amortization | 227.62% | 213.02% | 34.08% | 35.61% | 10.56% |
| Other Operating Expenses | 237.09% | 222.04% | 255.26% | 259.15% | 1,820.27% |
| Total Operating Expenses | 73.57% | 65.72% | 76.61% | 78.56% | 34.91% |
| Operating Income | -198.73% | -194.23% | -130.77% | -131.11% | -46.41% |
| Income Before Tax | -2,821.13% | -2,697.76% | -116.54% | -116.72% | -69.90% |
| Income Tax Expenses | -55.57% | -48.51% | -99.96% | -99.96% | -178.20% |
| Earnings from Continuing Operations | -1,742.29% | -1,667.96% | -124.19% | -124.45% | -37.40% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1,742.22% | -1,667.89% | -124.19% | -124.45% | -37.40% |
| EBIT | -198.73% | -194.23% | -130.77% | -131.11% | -46.41% |
| EBITDA | -184.14% | -180.34% | -129.43% | -129.74% | -45.95% |
| EPS Basic | -1,348.82% | -1,297.08% | -124.09% | -124.42% | -37.27% |
| Normalized Basic EPS | -278.79% | -268.66% | -116.67% | -116.67% | -70.00% |
| EPS Diluted | -1,348.82% | -1,297.08% | -124.09% | -124.42% | -37.27% |
| Normalized Diluted EPS | -278.79% | -268.66% | -116.67% | -116.67% | -70.00% |
| Average Basic Shares Outstanding | 31.21% | 31.21% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 31.21% | 31.21% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |